{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:16:49Z","timestamp":1760548609870},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.lpm.2007.04.033","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T06:05:18Z","timestamp":1201327518000},"page":"1857-1864","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Strat\u00e9gies pour\u00a0faire r\u00e9gresser les\u00a0l\u00e9sions de\u00a0fibrose r\u00e9nale"],"prefix":"10.1016","volume":"36","author":[{"given":"Jean-Jacques","family":"Boffa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.04.033_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.04.033_bib2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/ki.1997.455","article-title":"Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility","volume":"52","author":"Mott","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/ajkd.2002.31399","article-title":"Regression of IgA nephropathy: a repeat biopsy study","volume":"39","author":"Hotta","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lpm.2007.04.033_bib4","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1046\/j.1523-1755.2002.00357.x","article-title":"Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy","volume":"61","author":"Hill","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004872-200018010-00015","article-title":"Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy","volume":"18","author":"Konishi","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2007.04.033_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s001250051259","article-title":"Glomerular hypertension as one cause of albuminuria in type II diabetic patients","volume":"42","author":"Imanishi","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.lpm.2007.04.033_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/01.CIR.100.18.1901","article-title":"Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism","volume":"100","author":"Boffa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.04.033_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","article-title":"Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases","volume":"14","author":"Boffa","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)64130-2","article-title":"Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors","volume":"158","author":"Ruiz-Ortega","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2007.04.033_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.04.033_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm1275","article-title":"Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach","volume":"11","author":"Lautrette","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2007.04.033_bib13","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/ndt\/14.12.2860","article-title":"Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation","volume":"14","author":"Ng","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2007.04.033_bib14","first-page":"563","article-title":"Early role of Fsp1 in epithelial-mesenchymal transformation","volume":"273","author":"Okada","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lpm.2007.04.033_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2007.04.033_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2002.00430.x","article-title":"Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies","volume":"62","author":"Rastaldi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000106015.29070.E7","article-title":"Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention","volume":"15","author":"Liu","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1681\/ASN.V13196","article-title":"Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis","volume":"13","author":"Yang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1096\/fj.02-0442fje","article-title":"Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5\/6 nephrectomized mice","volume":"17","author":"Inoue","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.lpm.2007.04.033_bib20","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2006030278","article-title":"Renal bone morphogenetic protein-7 protects against diabetic nephropathy","volume":"17","author":"Wang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2007.04.033_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1681\/ASN.V13suppl_1s14","article-title":"Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function","volume":"13","author":"Morrissey","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/diacare.27.5.1164","article-title":"Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy","volume":"27","author":"Roestenberg","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lpm.2007.04.033_bib25","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/01.ASN.0000130565.69170.85","article-title":"Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis","volume":"15","author":"Yokoi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2004040339","article-title":"Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis","volume":"16","author":"Okada","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ki.5001731","article-title":"Modulator of bone morphogenetic protein activity in the progression of kidney diseases","volume":"70","author":"Yanagita","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib28","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1097\/01.ASN.0000139066.77892.04","article-title":"Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model","volume":"15","author":"Kelly","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.ki.5000376","article-title":"Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model","volume":"69","author":"Kelly","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib30","first-page":"239","article-title":"Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy","volume":"63","author":"Shimizu","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.lpm.2007.04.033_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.1998.00962.x","article-title":"Pirfenidone improves renal function and fibrosis in the post-obstructed kidney","volume":"54","author":"Shimizu","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.ASN.0000115400.52705.83","article-title":"Role of the coagulation\/fibrinolysis system in fibrin-associated glomerular injury","volume":"15","author":"Hertig","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib33","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2004060492","article-title":"Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1","volume":"16","author":"Ma","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib34","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1681\/ASN.2004090804","article-title":"Regression of existing glomerulosclerosis by inhibition of aldosterone","volume":"16","author":"Aldigier","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/hc0402.102929","article-title":"Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1","volume":"105","author":"Pahor","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.04.033_bib36","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1096\/fj.03-0084fje","article-title":"Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta","volume":"17","author":"Hertig","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.lpm.2007.04.033_bib37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI0216219","article-title":"Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy","volume":"110","author":"Yang","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2007.04.033_bib38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1681\/ASN.V124736","article-title":"TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy","volume":"12","author":"Kim","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.semnephrol.2007.02.006","article-title":"Matrix metalloproteinases (MMPs) in kidney disease progression and repair: A case of flipping the coin","volume":"27","author":"Ronco","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jcb.20605","article-title":"Diverse biological functions of extracellular collagen processing enzymes","volume":"96","author":"Trackman","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.lpm.2007.04.033_bib41","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/01.ASN.0000079614.63463.DD","article-title":"Tissue transglutaminase and the progression of human renal scarring","volume":"14","author":"Johnson","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000151333.56089.66","article-title":"Small artery remodeling depends on tissue-type transglutaminase","volume":"96","author":"Bakker","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2007.04.033_bib43","first-page":"868","article-title":"Compensatory growth of glomeruli is accomplished by an increased number of glomerular capillaries","volume":"70","author":"Marcussen","year":"1994","journal-title":"Lab Invest"},{"key":"10.1016\/j.lpm.2007.04.033_bib44","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.1995.158","article-title":"Glomerular morphometry in childhood reflux nephropathy, emphasizing the capillary changes","volume":"47","author":"Akaoka","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.ki.5000221","article-title":"The VHL\/HIF oxygen-sensing pathway and its relevance to kidney disease","volume":"69","author":"Haase","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib46","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1053\/hupa.2000.20373","article-title":"Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor","volume":"31","author":"Choi","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lpm.2007.04.033_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000088405","article-title":"Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy","volume":"102","author":"Namikoshi","year":"2006","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.lpm.2007.04.033_bib48","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1681\/ASN.V1271448","article-title":"Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function","volume":"12","author":"Kang","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib49","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.ki.5000060","article-title":"ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease","volume":"69","author":"Remuzzi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2007.04.033_bib50","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/01.ASN.0000095248.91994.D3","article-title":"Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats","volume":"14","author":"Adamczak","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/hh2001.097691","article-title":"Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway","volume":"89","author":"Silvestre","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2007.04.033_bib52","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2005020205","article-title":"Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth","volume":"17","author":"Liang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2007.04.033_bib53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nm1460","article-title":"Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice","volume":"12","author":"Ding","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2007.04.033_bib54","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1096\/fj.02-1062fje","article-title":"Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors","volume":"17","author":"Warnecke","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.lpm.2007.04.033_bib55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/labinvest.3700328","article-title":"Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model","volume":"85","author":"Tanaka","year":"2005","journal-title":"Lab Invest"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207004794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207004794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:58:15Z","timestamp":1630609095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207004794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0755498207004794"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.04.033","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}